See more : Mobicon Group Limited (1213.HK) Income Statement Analysis – Financial Results
Complete financial analysis of NuGen Medical Devices Inc. (NGMDF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NuGen Medical Devices Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Comp S.A. (CMP.WA) Income Statement Analysis – Financial Results
- Evolus, Inc. (0K16.L) Income Statement Analysis – Financial Results
- Kinergy Corporation Ltd. (3302.HK) Income Statement Analysis – Financial Results
- PT Tempo Inti Media Tbk (TMPO.JK) Income Statement Analysis – Financial Results
- Tera Software Limited (TERASOFT.NS) Income Statement Analysis – Financial Results
NuGen Medical Devices Inc. (NGMDF)
About NuGen Medical Devices Inc.
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventional/pediatric vaccines. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 331.40K | 152.36K | 137.65K | 47.30K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 166.56K | 705.59K | 45.42K | 12.91K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 164.84K | -553.23K | 92.22K | 34.39K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 49.74% | -363.11% | 67.00% | 72.70% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 7.52M | 4.24M | 1.72M | 0.00 | 995.65K | 603.33K | 415.77K |
| Selling & Marketing | 0.00 | 0.00 | 6.05M | 2.65M | 478.44K | 582.57K | 98.78K |
| SG&A | 7.52M | 4.24M | 7.76M | 2.65M | 132.14K | 1.66M | 608.03K |
| Other Expenses | 690.84K | 57.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 8.21M | 4.24M | 7.76M | 2.65M | 132.14K | 1.65M | 610.57K |
| Cost & Expenses | 8.38M | 4.95M | 7.81M | 2.66M | 132.14K | 1.65M | 610.57K |
| Interest Income | 0.00 | 150.91K | 20.00K | 22.85K | 0.00 | 136.87K | 104.42K |
| Interest Expense | 1.24M | 1.01M | 1.22M | 672.19K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 690.84K | 652.40K | 626.94K | 387.78K | 1.20K | 1.29K | 1.76K |
| EBITDA | -7.40M | -4.14M | -5.17M | -2.22M | -132.14K | -1.66M | -608.03K |
| EBITDA Ratio | -2,233.32% | -2,718.36% | -4,979.77% | -5,135.51% | 0.00% | 0.00% | 0.00% |
| Operating Income | -8.05M | -4.79M | -7.67M | -2.61M | -132.14K | -1.66M | -609.79K |
| Operating Income Ratio | -2,428.48% | -3,146.56% | -5,573.13% | -5,521.05% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.28M | -780.71K | -1.31M | -1.05M | -24.20K | -129.70K | -105.20K |
| Income Before Tax | -9.33M | -5.57M | -7.10M | -3.66M | -156.34K | -1.79M | -714.98K |
| Income Before Tax Ratio | -2,814.83% | -3,658.98% | -5,161.08% | -7,734.93% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 33.80K | 3.18K | 2.96K | 12.17K | -1.20K | 0.00 | 0.00 |
| Net Income | -9.36M | -5.58M | -7.11M | -3.67M | -156.34K | -1.79M | -714.98K |
| Net Income Ratio | -2,825.02% | -3,661.07% | -5,163.23% | -7,760.66% | 0.00% | 0.00% | 0.00% |
| EPS | -0.06 | -0.06 | -0.10 | -0.14 | -0.03 | -0.09 | -0.07 |
| EPS Diluted | -0.06 | -0.06 | -0.10 | -0.14 | -0.03 | -0.09 | -0.07 |
| Weighted Avg Shares Out | 167.66M | 90.10M | 68.67M | 27.05M | 4.75M | 19.65M | 9.70M |
| Weighted Avg Shares Out (Dil) | 167.66M | 90.10M | 68.67M | 27.05M | 4.75M | 19.65M | 9.70M |
NuGen Medical Appoints Industry Leader Ian Heynen as CEO
Toronto, Ontario--(Newsfile Corp. - October 12, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle free devices to administer therapeutics subcutaneously, is pleased to announce it has appointed Mr. Ian Heynen as...
Semaglutide - Ozempic(R) is Chemically Stable When Administered Using NuGen's Needle Free InsuJet(TM) Device
Toronto, Ontario--(Newsfile Corp. - October 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle free devices to administer therapeutics subcutaneously, today presented new data from a preliminary trial that semaglutide (Ozempic®)...
NuGen Medical Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania
Toronto, Ontario--(Newsfile Corp. - September 20, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has completed the delivery and sale of the first 500 units of the Company's needle-free InsuJet™ injector...
NuGen Receives $1.3M Through Early Option and Warrant Exercise
Toronto, Ontario--(Newsfile Corp. - September 11, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has received $1,302,000 through the exercise of 25,290,000 warrants having an exercise price of $0.05 expiring February...
NuGen Announces Participation at the 2023 Kinvestor Days Virtual Conference Tech Day
Toronto, Ontario--(Newsfile Corp. - September 5, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen"), is pleased to announce that Richard Buzbuzian, NuGen's President, CEO and Director, and Karen Dunlap, Chief Customer Officer and Director, are scheduled...
NuGen Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - August 4, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to provide shareholders the following corporate update. Corporate mission: NuGen's mission is to reduce the daily burden of diabetes care...
NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry
Toronto, Ontario--(Newsfile Corp. - July 25, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has entered into a distribution agreement for its needle-free InsuJet™ medical device and consumables with Sol-Millennium Medical...
Source: https://incomestatements.info
Category: Stock Reports